Literature DB >> 929648

Intestinal 1,25-dihydroxyvitamin D3 binding protein: specificity of binding.

J A Eisman, H F DeLuca.   

Abstract

The binding of metabolites of vitamin D and their analogs to the 3.7S chick intestinal cytosol receptor protein has been specifically studied by competitive binding techniques and polyethylene glycol precipitation of the complex. The structural requirements for the interaction between the vitamin D molecule and the receptor could be assessed without the nuclear chromatin binding step. These measurements have shown that 1,25-dihydroxyvitamin D3 and 1,25-dihydroxyvitamin D2 are equally competitive and are the most active. Of the structural features of the compounds, the 1 alpha-hydroxyl is most important followed by the 25-hydroxyl and the 3 beta-hydroxyl. The addition of a second hydroxyl near carbon 25 markedly reduces binding whether on the 26 carbon or the 24 carbon. A hydroxyl on C-24 could substitute to some degree for the 25-hydroxyl inasmuch as 24-hydroxyvitamin D3 was much more effective than vitamin D3 but less effective than 25-hydroxyvitamin D3. In general the patterns of binding affinities correlated well with the biological activity of the various analogs strongly supporting a physiological role for the 1,25-dihydroxyvitamin D3 binding protein. It also suggests that of the two-step receptor mechanism, the structural specificity is located in the initial interaction of the 1,25-dihydroxyvitamin D3 and the cytosol receptor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929648     DOI: 10.1016/0039-128x(77)90085-x

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  10 in total

1.  Detection of 1α,25-dihydroxyvitamin D-regulated miRNAs in zebrafish by whole transcriptome sequencing.

Authors:  Theodore A Craig; Yuji Zhang; Andrew T Magis; Cory C Funk; Nathan D Price; Stephen C Ekker; Rajiv Kumar
Journal:  Zebrafish       Date:  2014-03-20       Impact factor: 1.985

2.  Induction of matrix Gla protein synthesis during prolonged 1,25-dihydroxyvitamin D3 treatment of osteosarcoma cells.

Authors:  J D Fraser; P A Price
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

3.  A monolog on analogs: in vitro effects of vitamin D metabolites and consideration of the mineralization question.

Authors:  P H Stern
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

Review 4.  Vitamin D, disease and therapeutic opportunities.

Authors:  Lori A Plum; Hector F DeLuca
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

5.  The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease.

Authors:  Mandy E Turner; Tyler S Rowsell; Christine A White; Martin Kaufmann; Patrick A Norman; Kathryn Neville; Martin Petkovich; Glenville Jones; Michael A Adams; Rachel M Holden
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

6.  Vitamin D status and outcomes after renal transplantation.

Authors:  Frank Bienaimé; Delphine Girard; Dany Anglicheau; Guillaume Canaud; Jean Claude Souberbielle; Henri Kreis; Laure Hélène Noël; Gérard Friedlander; Caroline Elie; Christophe Legendre; Dominique Prié
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

7.  Biologically active noncalcemic analogs of 1alpha,25-dihydroxyvitamin D with an abbreviated side chain containing no hydroxyl.

Authors:  Lori A Plum; Jean M Prahl; Xiaohong Ma; Rafal R Sicinski; Sumithra Gowlugari; Margaret Clagett-Dame; Hector F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

8.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

Authors:  P R Skolnik; B Jahn; M Z Wang; T R Rota; M S Hirsch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.

Authors:  E Abe; C Miyaura; H Sakagami; M Takeda; K Konno; T Yamazaki; S Yoshiki; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

Review 10.  Impaired vitamin D metabolism in CKD.

Authors:  Cortney Bosworth; Ian H de Boer
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.